Format

Send to

Choose Destination
Sci Transl Med. 2019 May 8;11(491). pii: eaax7315. doi: 10.1126/scitranslmed.aax7315.

Tinkering with the vasopressin pathway in autism.

Author information

1
CHU Sainte-Justine Research Center, Montréal, Quebec H3T 1C5, Canada. sebastien.jacquemont@umontreal.ca b.forgeot@gmail.com.
2
Department of Psychiatry, Université de Montréal, Montréal, Quebec H3C 3J7, Canada.
3
Centre intégré Universitaire du Nord-de-l'Île-de-Montréal, Montréal, Quebec H1E 1A4, Canada.
4
McGill University, Montréal, Quebec H3A 0G4, Canada.
5
Montreal Neurological Institute, Montréal, Quebec H3A 2B4, Canada.
6
Department of Pediatrics, Université de Montréal, Montréal, Quebec H3C 3J7, Canada.

Abstract

Two clinical trials targeting the vasopressin pathway in autism highlight continuing challenges in outcome measures and statistical power.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center